G. Stewart

Transthyretin Val122Ile amyloidosis associated with isolated gastrointestinal disease and bowel rupture in a Caucasian woman.

D. Booth, S. Ting, P. Hosking, 2019, Pathology.

Does the BRAFV600E mutation herald a new treatment era for Erdheim–Chester disease? A case‐based review of a rare and difficult to diagnose disorder

J. Bosco, G. Stewart, A. Allende, 2015, Internal medicine journal.

Amyloid Cardiomyopathy.

D. Fatkin, L. Thomas, J. Atherton, 2019, Heart, lung & circulation.

Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study

E. Nordh, Yi-Chung Lee, R. Sommerville, 2020, Lancet Neurology.

Amyloidosis in Australia

S. Gibbs, P. Mollee, G. Stewart, 2019, Expert Opinion on Orphan Drugs.

Alterations in multi-layer strain in AL amyloidosis

D. Richards, A. Boyd, L. Thomas, 2022, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Current approaches to the diagnosis and management of amyloidosis

S. Vucic, J. Baumwol, P. Mollee, 2022, Internal medicine journal.

Correlation Between Quantitative Uptake of 99mTC-DPD and Echocardiographic Parameters in Cardiac ATTR: A Novel Follow-Up Strategy

L. Thomas, D. Farlow, P. Geenty, 2021, Frontiers in Cardiovascular Medicine.

Correlation of Quantitative 99mTc DPD Scintigraphy With Echocardiographic Alterations in Left Atrial Parameters in Transthyretin Amyloidosis.

L. Thomas, D. Farlow, P. Geenty, 2022, Heart, lung & circulation.

Impact of Vutrisiran on Quality of Life and Physical Function in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy

Karla P. Zepeda, Hansie M Mathelier, J. Felius, 2023, Neurology and Therapy.

Left Ventricular Mass-To-Strain Ratio Predicts Cardiac Amyloid Subtype.

D. Richards, L. Thomas, L. Stefani, 2020, JACC. Cardiovascular imaging.